About Triblant

Triplant

Experience TRIPLANT, the next generation living implant that will help you keep all 28 of your teeth strong until you’re 100 years old.
About 28vc ans Blockchain

28vc+BlockChain

Through the commercialization of [TRIPLANT], the innovative living implant, we plan to maximize healthy living and social value for our long-living generation and actualize future technology and maximize contributions to human society.

In line with the development of a new level of TRIPLANT, we are undergoing efficient and fair profit distribution, as well as commercialization, by linking the recruitment of clinical trial subjects with the blockchain system.

TRIPLANT Dental Solution
Revolution
of living implants

TRIPLANT Dental Solution will revolutionize living implants with innovative implant ideas and the blockchain technology that cannot be replicated.

More info
28 Enjoy Eternity

Revolution of implants, TRIPLANT

Medical

28VC partnering with leading institutions in the countryC

Dental

Invention that actualizes anatomical and histological features similar to one’s natural teeth

Blockchain Voucher

Prevention of monopoly in the implant market by issuing blockchain-based tokens

The beginning of a revolution,
What is TRIPLANT?

The TRIPLANT Dental Solution will revolutionize living implants with innovative implant ideas and the blockchain technology that cannot be replicated. Watch a video
Triplant Point

Three features of TRIPLANT

1
Regeneration of blood vessels and nerves

Securing of vertical/horizontal regeneration pathways inside and outside of implants in the blood vessels and nerves

2
Protection provided by 3 circular barrier rings

3 circular barrier ring shield design in the upper part of the implant

3
Intact alveolar bone

Design in which the alveolar bone lost during implantation gathers inside the TRIPLANT

Products Detail
Triplant
Products Detail
Triplant
Products Detail
Triplant
Products Detail
Triplant
Products Detail
Triplant
Products Detail
Triplant
Global Market
Implant systems worldwide
The continuously growing implant market is showing an average growth rate of 8.2% annually.
Implant Global Market Growth Rate

Unit: U.S. Dollars

Significance of the global dental implant market

Medical market research institute iData

About 28VC - 01
Purpose of issuance of 28VC
28VC was issued as a blockchain token to prevent monopolies in the implant market through the issuance of a blockchain-based token for the financing of venture businesses with good technology and to prevent unclear fund investment conducted by the institutional investors. It aims to secure clients at the time of its commercialization in the future through the transparency in fund execution and conduction of preliminary pre-marketing.
About 28VC - 02
28VC Distribution

Recruitment of vouchers for 24 months through the stock exchange after listing.
*Recruitment Criteria: Period of 24 months, 20% for token distribution, and the 65% allotted to the TRIPLANT Dental Council will remain locked for 36 months. Once the cloud sale is completed, the listing price is determined and reflected based on the opinions of the holders when listed on the stock exchange.

* We are preparing to advance into various countries including the United States and Indonesia.
About 28VC - 03
Use of funds for 28VC

28VC is using 70% of the funds for R&D and production, and it is directing all its attention on business development, market research, and marketing.

property 28VC
Intellectual property
Intellectual Property :: Applications for Japan, USA, EU PCT
Advisor
28VC Advisor
Masaki Kambara Osaka Dental University, Hirakata, Japan.

01

Unience Co., Ltd.

Simple cancer diagnosis development
by the medical appliances R&D company, TRIPLANT R&D (possession of patent)

02

Unience Japan Co., Ltd.
Unience China Co., Ltd.

Scheduled for establishment

03

Tooth Co., Ltd.

Signed a contract with Unience Co., Ltd. to distribute TRIPLANT, conduct pre-marketing, and recruit clinical trial subjects (Korea, Japan, China, Indonesia, Vietnam, etc.)

Triplant Road Map
TRIPLANT
is the future.
2019

Design modification and sample development of TRIPLANT
Preparation to proceed with studies on the safety and efficacy of clinical results in human subjects

2020

Proceed with studies on the safety and efficacy of clinical results in human subjects
Equipment for implant procedure / 3D printer / milling machine / preparation of various consumables relevant to the computer and auxiliary facilities

2021

3,000 cases of clinical trials for examinees
Equipment for implant procedure / 3D printer / milling machine / preparation of various consumer goods related to computers and subsidiary facilities

2022

Aims to complete registration of medical devices by the Ministry of Food and Drug Safety
Presentation of 6 international papers and overseas academic publications

2023

Sales of TRIPLANT/ Distribution structure/ Development of the overseas industry
Start the development of alveolar bones as a secondary research industry

2020

Voucher and tree issuance at the end of November 2020, distribution of white paper
System established in December 2020 (wallet, website, SNS, etc.)
Plans for listing in December 2020 (marketing, promotion, and standardization)

2021 1Q

January: 1st Tooth Voucher Business Reporting Contest (held before listing, may change depending on the hosting of the Coronavirus assembly)
Opening and operation of Shinhan University’s TRIPLANT Central Research Center
Commencement of the undertaking work of Dongjak Gyeonghui Hospital for stable use of 28VC and completion of the plan for the establishment of a general hospital specializing in TRIPLANT procedure
Listed in March (may change depending on system establishment, cloud sales situation)
Conduct joint research with research institutes of relevant universities at two research institute headquarters
Procedural initiation of implant clinical trials with the primary TRIPLANT prototype
Scheduled for sales in Japan

2021 2Q

May: Acquisition of Dongjak Gyeonghui Hospital in progress
Payment with 28VC (dental vaccination, etc.)
Scheduled for sales in China (Bitmart IEO and listing on the United States stock exchange)

2021 3Q

August: Opening of a clinic, event, exchange market, execution of the clinical trial, symposium, etc.
Establishment of a network all across the country for the clinical subject procedure of TRIPLANT
Establishment and operation of the primary clinical hospital in the Guangdong Province - in connection with Korea
Scheduled for sales in Indonesia

2021 4Q

Establishment of TRIPLANT’s central corporation in Beijing
Establishment of a TRIPLANT Hospital in Shanghai
Early establishment of TRIPLANT Academy in Chongqing Tree, Tokyo, Jeju, and Beijing